Novel Aspects of Nonfasting Lipemia in relation to Vascular Biology by Castro Cabezas, M. et al.
Hindawi Publishing Corporation
International Journal of Vascular Medicine
Volume 2012, Article ID 419015, 2 pages
doi:10.1155/2012/419015
Editorial
Novel Aspects of Nonfasting Lipemiain relation to
VascularBiology
M. CastroCabezas,1 Kathleen M. Botham,2 John C.L. Mamo,3 andSpencer D.Proctor4
1Department of Internal Medicine, Center for Diabetes and Vascular Medicine, STZ Center of Expertise, St. Franciscus Gasthuis
P.O. Box 10900, Rotterdam, BA 3004, The Netherlands
2Department of Veterinary Basic Sciences, The Royal Veterinary College, Royal College Street, London NW1 0TU, UK
3Centre for Metabolic Fitness, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University,
P.O. Box U1987, Perth, WA 6845, Australia
4Department of Agriculture, Food and Nutritional science, University of Alberta, Edmonton, AB, Canada T6G 2P5
Correspondence should be addressed to M. Castro Cabezas, m.castrocabezas@sfg.nl
Received 15 January 2012; Accepted 15 January 2012
Copyright © 2012 M. Castro Cabezas et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Several cardiovascular risk factors have been described
during the last decades. Postprandial hyperlipidemia has
been recognized as an important factor contributing to
atherogenesis;howeverchylomicronremnants have not been
used widely in risk equations. One of the probable causes
for this lack of consideration in clinical practice may be
that the metabolism of chylomicrons and their remnants
has been rather diﬃcult to study and, more so, to modulate
in vivo. The current issue of the International Journal of
Vascular Medicine provides novel insight into the metabolic
changes of chylomicrons and their remnants in relation to
vascular damage. The paper by G. H. Tomkin and D. Owens
“The chylomicron: relationship to atherosclerosis”p r o v i d e sa n
excellent overview of the molecular mechanisms involved
in chylomicron synthesis and metabolism in humans. The
paper by B. Klop et al. “Understanding postprandial inﬂam-
mation and its relationship to lifestyle behaviour and metabolic
diseases” describes novel aspects related to inﬂammation
in diﬀerent clinical conditions and under variable lifestyle
situations. Following this line of inﬂammatory-dependent
aspects of chylomicrons, the paper by M. Cao et al. “Dual
AAV/IL-10 plus STAT3 anti-inﬂammatory gene delivery lowers
atherosclerosis in LDLR KO mice, but without increased
beneﬁt” further explores aspects of cholesterol metabolism
involvingdiﬀerentmoleculartargetsimportantforbothhep-
atic and intestinal cholesterol metabolism. S. A. Lopez et al.
proceedwithapaperinvestigatingtheeﬀectsofoxidizedchy-
lomicron remnants on monocyte activation and the eﬀects
of the antioxidant drug probucol on this interaction “The ox-
idative state of chylomicron remnants inﬂuences their mod-
ulation of human monocyte activation.” L. D. Roche and
et al. provide evidence suggesting that postprandial hyper-
triglyceridemia simulated by an infusion with artiﬁcial TG-
rich lipoproteins (Lipofundin) induces oxidative stress and
atherosclerotic lesions in an animal model prone to develop
atherosclerosis “Lipofundin-induced hyperlipidemia promotes
oxidative stress and atherosclerotic lesions in New Zealand
white rabbits.”
The paper by M. Napolitano et al. “Phospholipase A2 me-
diates apolipoprotein-independent uptake of chylomicron rem-
nant-like particles by human macrophages” includes novel
work showing that macrophage lipolytic enzymes mediate
the internalization of postprandial TG-rich lipoproteins
and that secretory phospholipase A2 (sPLA2) and cytoso-
lic PLA2 play a more important role than extracellular
lipoprotein lipase-mediated TG hydrolysis. M. M. Pallebage-
Gamarallage et al. describe in the following investigation
“A diet enriched in docosahexanoic acid exacerbates brain
parenchymal extravasation of Apo B lipoproteins induced by
chronic ingestion of saturated fats,” how dietary interventions
can lead to modulation of cerebrovascular inﬂammation by
oxidative stress. A. Van der Wiel provides a comprehensive2 International Journal of Vascular Medicine
update on the eﬀects of alcohol ingestion on fasting and
postprandial triglyceridemia “The eﬀect of alcohol on post-
prandial and fasting triglycerides”, which is followed by a
paper by B. Klop et al. “AT1 receptor gene polymorphisms in
relation topostprandiallipemia”showinganovel relationship
between polymorphisms of genes involved in the regulation
ofbloodpressurewithpostprandiallipemia.J.P.H.vanWijk
and M. Castro Cabezas contributed with an update on the
eﬀects of antiretroviral therapy in HIV-infected patients on
TG metabolism “Hypertriglyceridemia, metabolic syndrome,
and cardiovascular disease in HIV-infected patients: eﬀects of
antiretroviral therapy and adipose tissue distribution.” Finally,
G. Charach et al. provided a review describing the eﬀects
of bile acid secretion and intestinal absorption on plasma
lipoproteins and coronary atherosclerosis.
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